{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Piscataway",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {
        "application_number": [
          "ANDA210692"
        ],
        "brand_name": [
          "ATOVAQUONE"
        ],
        "generic_name": [
          "ATOVAQUONE"
        ],
        "manufacturer_name": [
          "Camber Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "31722-629"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ATOVAQUONE"
        ],
        "rxcui": [
          "308429"
        ],
        "spl_id": [
          "53e3680b-e7d0-82b4-e063-6394a90af9e8"
        ],
        "spl_set_id": [
          "2445304e-4b4e-4358-b098-31f3c49c52ef"
        ],
        "package_ndc": [
          "31722-629-21"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0331722629218"
        ],
        "nui": [
          "N0000175482",
          "N0000175485"
        ],
        "pharm_class_epc": [
          "Antimalarial [EPC]",
          "Antiprotozoal [EPC]"
        ],
        "unii": [
          "Y883P1Z2LT"
        ]
      },
      "product_type": "Drugs",
      "event_id": "91808",
      "recalling_firm": "Camber Pharmaceuticals Inc.",
      "address_1": "800 Centennial Ave Ste 1",
      "address_2": "N/A",
      "postal_code": "08854",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0567-2023",
      "product_description": "Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21.",
      "product_quantity": "1568 bottles",
      "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.",
      "recall_initiation_date": "20230313",
      "center_classification_date": "20230508",
      "report_date": "20230517",
      "code_info": "Lot# E220182, Exp. 12/31/2023"
    }
  ]
}